Matthias Hagner

Matthias Hagner

Auto-generated profile, based on publicly available information

Matthias Hagner

Pieris Pharmaceuticals GmbH

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2020 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MHMatthias Hagner
Matthias Hagner
MAMelanie Albrecht
Melanie Albrecht
MGMatteo Guerra
Matteo Guerra
PBPeter Braubach
Peter Braubach
OHOlga Halle
Olga Halle
MMMarcus Mall
Marcus Mall
Background: Elevated levels of interleukin (IL)-17A were detected in the airways of patients with cystic fibrosis (CF), but its cellular sources and role in the pathogenesis of CF lung disease remain poorly understood. The aim of this study was to determine the sources of IL-17A and its role in airway inflammation and lung damage in CF.Methods: We performed flow cytometry to identify IL-17A-producing cells in lungs and peripheral blood from CF patients and β-epithelial Na+ channel transgenic (Scnn1b-Tg) mice with CF-like lung disease, and determined the effects of genetic deletion of Il17a and Rag1 on the pulmonary phenotype of Scnn1b-Tg mice.Results: T-helper 17 cells, CD3+CD8+ T-cells, γδ T-cells, invariant natural killer T-cells and innate lymphoid cells contribute to IL-17A secretion in lung tissue, lymph nodes and peripheral blood of patients with CF. Scnn1b-Tg mice displayed increased pulmonary expression of Il17a and elevated IL-17A-producing innate and adaptive lymphocytes with a major contribution by γδ T-cells. Lack of IL-17A, but not the recombination activating protein RAG1, reduced neutrophilic airway inflammation in Scnn1b-Tg mice. Genetic deletion of Il17a or Rag1 had no effect on mucus obstruction, but reduced structural lung damage and revealed an IL-17A-dependent macrophage activation in Scnn1b-Tg mice.Conclusions: We identify innate and adaptive sources of IL-17A in CF lung disease. Our data demonstrate that IL-17A contributes to airway neutrophilia, macrophage activation and structural lung damage in CF-like lung disease in mice. These results suggest IL-17A as a novel target for anti-inflammatory therapy of CF lung disease.

5 March 2020 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MHMatthias Hagner
Matthias Hagner
DFDario Frey
Dario Frey
MGMatteo Guerra
Matteo Guerra
ADA. Susanne Dittrich
A. Susanne Dittrich
VHVictoria S. Halls
Victoria S. Halls
MMMarcus Mall
Marcus Mall
Increased activity of the serine protease neutrophil elastase (NE), secreted by activated neutrophils in the airways, is a key risk factor for the onset and progression of structural lung damage and lung function decline in patients with cystic fibrosis (CF) and non-CF bronchiectasis [1–6]. In addition to progressive structural lung damage, increased NE activity has been implicated in mucus hypersecretion [7–9], perpetuation of airway inflammation [10], and impaired host defence against Pseudomonas aeruginosa infection [6, 11–13]. These studies suggest increased NE activity in sputum or bronchoalveolar lavage fluid (BALF) as a promising biomarker of airway inflammation in CF and potentially other neutrophilic airway diseases [2–4, 6].

1 November 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
TBThayse R. Brüggemann
Thayse R. Brüggemann
NKNandini Krishnamoorthy
Nandini Krishnamoorthy
MHMatthias Hagner
Matthias Hagner
GMGabriele Matschiner
Gabriele Matschiner
TJThomas Jaquin
Thomas Jaquin
BLBruce Levy
Bruce Levy
This is the first report of an Anticalin protein engineered to neutralize IL-23 (AcIL-23). Airway administration of AcIL-23 in mice regulated allergen-driven airway inflammation, mucous cell metaplasia, and methacholine-induced airway hyperresponsiveness. In mixed granulocytic allergic lung inflammation, immune regulation of IL-23 was broader than neutralization of either IL-17 or IL-5.

1 January 2025 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
KHKatharina Heinzelmann
Katharina Heinzelmann
AFAthanasios Fysikopoulos
Athanasios Fysikopoulos
TJThomas J. Jaquin
Thomas J. Jaquin
JPJanet K. Peper-Gabriel
Janet K. Peper-Gabriel
EHEva-Maria Hansbauer
Eva-Maria Hansbauer
MHMatthias Hagner
Matthias Hagner
Airway mucus drives severity and mortality in diverse chronic lung diseases. The Jagged-1/Notch pathway controls the balance of ciliated versus mucous cells, but targeting the pathway systemically carries the risk of side effects. Here we developed novel, Anticalin-derived, pulmonary-delivered Jagged-1 antagonists, to inhibit airway mucus hyperproduction and obstruction in chronic lung diseases. Our preclinical data demonstrate the effectiveness of these antagonists in diminishing secretory cell and mucus levels and alleviating hallmarks of mucus obstruction.

14 July 2015 in Pneumologie
Verified
Journal Article
Closed access
BFB Fritzsching
B Fritzsching
LDL Dai
L Dai
CBC van Bodegom
C van Bodegom
JSJ Schatterny
J Schatterny
SHS Hirtz
S Hirtz
MMMa Mall
Ma Mall
Introduction: We have previously demonstrated that mice with airway specific overexpression of the amiloride-sensitive epithelial Na+ channel (βENaC-Tg) and mice lacking the epithelial Cl- channel SLC26A9 suffer from airway surface dehydration and airway mucus obstruction, which might be implicated in the pathogenesis of allergic airway disease (Anagnostopoulou et al., JCI 2012 and Mall et al., AmJRespirCritCare Med 2008). Here, we hypothesized that airway surface dehydration and reduced mucociliary clearance may increase the susceptibility for allergic airway inflammation. Methods: Aspergillus fumigatus extract (Af) was applied by intratracheal instillations into juvenile βENaC-Tg mice or WT mice (C57BL/6) and BAL cell counts, IL-13 levels and airway hyperresponsiveness (AHR, by Flexivent lung function) were determined. Genetic deletion of the IL-4/IL13 receptor signal transducer STAT6 was introduced to βENaC-Tg mice to analyze the contribution of type 2 inflammation to the Af immune response. Furthermore, preventive treatment of βENaC-Tg mice and WT mice with amiloride was performed and BAL and IL-13 levels were determined. Results: Airway eosinophils and pulmonary IL-13 expression were significantly increased in Af-challenged compared to vehicle-treated βENaC-Tg mice. Airway hyperresponsiveness was elevated in βENaC-Tg mice and increased further in response to Af treatment. Genetic deletion of STAT6 abrogated Af-induced airway eosinophilia and IL-13 expression in βENaC-Tg mice. Preventive treatment with amiloride significantly reduced allergic inflammataion in both βENaC-Tg and WT mice. Conclusion: Collectively, our results indicate that airway surface dehydration is a risk factor for key pathologies in allergic airway disease. Amelioration of airway surface dehydration (i.e. by amiloride) might constitute a novel target for prevention and treatment of allergic airway disease. Acknowledgements: DFG (DFG MA 2081/3 – 2) *Presenting author

14 July 2015 in Pneumologie
Verified
Journal Article
Closed access
SCS Christochowitz
S Christochowitz
CBC van Bodegom
C van Bodegom
SSS Schmidt
S Schmidt
EME Maier
E Maier
MHM Hagner
M Hagner
BFB Fritzsching
B Fritzsching
Introduction: We have previously demonstrated that mice with airway specific overexpression of the epithelial Na+ channel (βENaC-Tg) exhibit airway surface dehydration and eosinophilic airway inflammation in juvenile mice (Mall MA, Am J Respir Crit Care Med 2008). We hypothesized that airway surface dehydration may increase the susceptibility for allergic airway inflammation and treatment with allergen could induce IL-13 expression in vivo. Here, we evaluated cellular sources of IL-13 expression in response to allergen treatment in wild-type and βENaC-Tg mice. Methods: Juvenile wild-type and βENaC-Tg mice were challenged intratracheally for one week with Aspergillus fumigatus (Af) extract. In vitro restimulated whole lung-derived leukocytes were analyzed for IL-13 expression by multicolor flow cytometry. Laser microdissection (LMD) of the airway epithelium and subsequent nested qPCR were performed for quantification of airway-specific mRNA expression of IL-13, IL-33, IL-25, TSLP and periostin. IL-13 expression was confirmed by immunohistochemistry with IL13-/- mice-derived lung tissue as negative control. Results: Intrapulmonary exposure of Af significantly increased airway eosinophils and pulmonary IL-13 in βENaC-Tg mice. We observed elevated numbers of pulmonary IL-13+-cells among macrophages, Th2-, B- and ILC2-cells in βENaC-Tg mice by 11-color flow cytometry, which was further increased in response to Af treatment in Th2- and ILC2-cell populations. LMD revealed airway epithelial cell-specific expression of IL-13 and IL-33 but not TSLP and IL-25 in βENaC-Tg mice. Immunostaining confirmed epithelium-mediated IL-13 protein expression, which was enhanced after Af challenge in βENaC-Tg mice. Conclusion: We demonstrate that airway surface dehydration is a risk factor for allergic airway inflammation including increased frequencies of IL-13+-cells in response to allergen. Furthermore, expression of IL-13 is not limited to Th2 cells, but also ILC2 cells and airway epithelium provide substantial amounts of IL-13 in vivo. *Presenting author